Patient Refunds for Bad Denials Act of 2026
- Bill Number
- H.R. 8442
- Origin Chamber
- House
- Congress
- 119th Congress, Session 2
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2026-04-22: Referred to the House Committee on Energy and Commerce.
- Last Updated
- 2026-05-13T19:50:46Z
AI-Generated Summary
Purpose
The Patient Refunds for Bad Denials Act of 2026 (H.R. 8442) aims to hold health insurance companies accountable for excessively denying claims (rejected requests for payment on medical bills). It introduces financial penalties on companies with high denial rates and requires greater transparency when claims are denied, with penalty funds refunded to affected policyholders.
Key Provisions
- Civil Penalties for High Denial Rates (new Section 2799C-1):
- The Secretary of Health and Human Services (HHS) can fine health insurance companies offering group or individual plans if their claims denial percentage (share of submitted claims rejected) reaches 25% or higher (or a lower threshold set by HHS) in a plan year starting January 1, 2027, or later.
- Denials are calculated via HHS audits; exclusions apply for claims correctly denied due to fraud or lack of medical necessity (proven with evidence).
- Fine amount: $10 million base + $2 million per percentage point over 25%, adjustable for inflation; HHS considers company efforts to lower denials.
- Collected fines are distributed pro rata (proportionally) as refunds to enrollees in the penalized plans.
- Transparency Requirements (new Section 2730):
- Companies must provide denied claimants (for medical necessity reasons) a notice explaining the company's standards and why the claim failed them.
- Companies must report their overall claims denial rate to HHS annually.
- Applies to plan years beginning on or after January 1, 2027.
Significant Changes to Existing Law
- Adds a new Part F (Claims Denials) to Title XXVII of the Public Health Service Act, creating civil penalties tied directly to denial rates—previously, no such nationwide penalty structure existed for high denial volumes.
- Introduces mandatory transparency notices and annual denial rate reporting (new Section 2730 in Subpart II), enhancing consumer protections beyond current disclosure rules.
Potential Impacts
- Government Agencies: HHS gains authority for audits, enforcement, penalty collection/distribution, and data reporting—increasing administrative workload.
- Citizens/Policyholders: Potential direct refunds from penalties; clearer explanations for denials may reduce disputes and improve access to care.
- Health Insurance Companies: Financial incentives to lower denial rates; risk of multimillion-dollar fines could raise operational costs, possibly passed to premiums.
- No direct impacts on international relations.
Main Stakeholders Affected
- Health insurance issuers (companies offering group or individual plans): Face penalties, audits, and reporting burdens.
- Enrollees/policyholders: Benefit from refunds and transparency.
- HHS Secretary: Responsible for enforcement, audits, and fund distribution.
- Healthcare providers: Indirectly affected via fewer improper denials.
Notable Legal, Constitutional, or Political Implications
- Legal: Establishes a clear enforcement mechanism with audit-based evidence requirements, but issuers must prove fraud/necessity exclusions—could lead to litigation over audit fairness or penalty calculations.
- Constitutional: Potential due process concerns in audits/penalties (e.g., adequate notice and appeal rights implied but not detailed).
- Political: Promotes consumer protection by penalizing "bad denials," balancing insurer accountability with flexibility (e.g., lower thresholds, effort considerations); may influence debates on insurance regulation without altering core coverage mandates.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (1)
Recent Actions
- 2026-04-22: Referred to the House Committee on Energy and Commerce.
- 2026-04-22: Introduced in House
- 2026-04-22: Introduced in House
Bill Versions
- Patient Refunds for Bad Denials Act of 2026 — issued 2026-04-22 — PDF (5 pages)